Fatal inappropriate ICD shock

被引:37
作者
Veltmann, Christian [1 ]
Borggrefe, Martin [1 ]
Schimpf, Rainer [1 ]
Wolpert, Christian [1 ]
机构
[1] Univ Klinikum Mannheim, Dept Med, D-68167 Mannheim, Germany
关键词
implantable cardioverter defibrillator; proarrhythmia; inappropriate ICD therapy; proarrhythmic ICD shock;
D O I
10.1111/j.1540-8167.2006.00692.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Inappropriate implantable cardioverter defibrillator (ICD) therapy carries a low but relevant risk of ventricular proarrhythmia. In the present case, the extremely rare event of a fatal arrhythmia caused by inappropriate therapy is reported. Dislodgement of the ventricular lead to the level of the tricuspid annulus led to additional sensing of the atrial signal during sinus tachycardia. Spuriously, ventricular fibrillation was sensed and induced inappropriate ICD shocks. The fourth inappropriate shock caused ventricular fibrillation, which was subsequently undersensed by the dislodged lead due to low ventricular amplitudes. The ICD started antibradycardic pacing during ventricular fibrillation. After initial successful resuscitation, the patient died I week later due to severe hypoxic brain damage. Although not preventable in the present case, it underlines the necessity of immediate interrogation of the ICD after ICD therapy and deactivation of the ICD in the setting of a dislodged endocardial lead and intensive care monitoring of the patient until revision.
引用
收藏
页码:326 / 328
页数:3
相关论文
共 17 条
[11]   Experience with a dual chamber implantable defibrillator [J].
Kühlkamp, V ;
Wilkoff, BL ;
Brown, AB ;
Volosin, KJ ;
Hügl, BJ ;
Stafford, W ;
Cameron, DA .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2002, 25 (07) :1041-1048
[12]   Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators [J].
Luria, D ;
Glikson, M ;
Brady, PA ;
Lexvold, NY ;
Rasmussen, MJ ;
Hodge, DO ;
Chugh, SS ;
Rea, RF ;
Hayes, DL ;
Hammill, SC ;
Friedman, PA .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (07) :901-+
[13]  
Messali A, 2004, J CARDIOVASC ELECTR, V15, P953, DOI 10.1046/j.1540-8167.2004.03611.x
[14]   THE PROARRHYTHMIC POTENTIAL OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS [J].
PINSKI, SL ;
FAHY, GJ .
CIRCULATION, 1995, 92 (06) :1651-1664
[15]   Adverse events with transvenous implantable cardioverter-defibrillators - A prospective multicenter study [J].
Rosenqvist, M ;
Beyer, T ;
Block, M ;
den Dulk, K ;
Minten, J ;
Lindemans, F .
CIRCULATION, 1998, 98 (07) :663-670
[16]   Congenital short QT syndrome and implantable cardioverter defibrillator treatment: Inherent risk for inappropriate shock delivery [J].
Schimpf, R ;
Wolpert, C ;
Bianchi, F ;
Giustetto, C ;
Gaita, F ;
Bauersfeld, U ;
Borggrefe, M .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2003, 14 (12) :1273-1277
[17]   Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrittator [J].
Vollmann, D ;
Lüthje, L ;
Vonhof, S ;
Unterberg, C .
HEART RHYTHM, 2005, 2 (03) :307-309